Source comparison
TB-500 for Post-Surgery Patients: Comparison of Tissue-Specific Evidence
Research evidence for TB-500 varies significantly across tissue types. Not all post-surgical contexts show equal benefit. Dermal wounds (skin incisions) Epithelialization, keratinocyte migration, collagen remodeling High. Multiple RCTs in animal models 20–30%
This comparison does not assign a generated winner or score.
- Research evidence for TB-500 varies significantly across tissue types. Not all post-surgical contexts show equal benefit.
- Dermal wounds (skin incisions)
- Epithelialization, keratinocyte migration, collagen remodeling
- High. Multiple RCTs in animal models
- 20–30% faster wound closure, reduced scar width
- Strong evidence for accelerated healing in clean surgical wounds
- Skeletal muscle
- Satellite cell activation, myofiber regeneration
- Moderate. Controlled studies in rodent and equine models
- 30% faster return to weight-bearing function
- Evidence supports use in muscle repair contexts, though human data limited
- Tendons and ligaments
- Collagen organization, reduced type III collagen deposition
- Moderate. Equine and rodent tendon injury models
- 25% higher tensile strength at 90 days
- Promising for tendon repairs; mechanism clear but human translation unclear
- Bone fractures
- Indirect. Improved soft tissue healing around fracture site
- Low. Minimal direct evidence
- Modest improvement in periosteal healing
- Insufficient evidence for fracture healing specifically
- Nerve injuries
- Schwann cell migration, axonal regeneration support
- Preliminary. Early-stage rodent models only
- Variable; no consensus on magnitude
- Interesting mechanistic basis but insufficient data for recommendation